PLoS ONE · 2015 · 41 citations · 29 references
MedicineCell BiologyOncologyMetastasisMolecular OncologyNeuro-oncologyBrain TumorsCancer Stem Cell BiologyCancer Stem Cell MaintenanceCancer Stem CellsGlioblastomaStem Cell TumorigenicityCancer Metastasis MechanismsCancer Stem Cell TargetingCancer Stem-like CellsGlioblastoma Stem CellsGlioblastoma Therapeutic ResistanceIn Vitro Cell ExpansionStem Cell Marker ExpressionTherapy-resistant Cancer Stem Cells
Due to their stem-like characteristics and their resistance to existing chemo- and radiation therapies, there is a growing appreciation that cancer stem cells (CSCs) are the root cause behind cancer metastasis and recurrence. However, these cells represent a small subpopulation of cancer cells and are difficult to propagate in vitro. Glioblastoma is an extremely deadly form of brain cancer that is hypothesized to have a subpopulation of CSCs called glioblastoma stem cells (GSCs; also called brain tumor initiating cells, BTICs). We propose the use of selective Rho-kinase (ROCK) inhibitors, Y-27632 and fasudil, to promote GSC/BTIC-like cell survival and propagation in vitro. ROCK inhibitors have been implicated in suppressing apoptosis, and it was hypothesized that they would increase the number of GSC/BTIC-like cells grown in vitro and improve cloning efficiencies. Indeed, our data demonstrate that transient and continuous supplementation of non-toxic concentrations of Y-27632 and fasudil inhibited apoptosis, enhanced the cells' ability to form spheres, and increased stem cell marker expressing GSC/BTIC-like cell subpopulation. Our data indicated that pharmacological and genetic (siRNA) inhibitions of the ROCK pathway facilitates in vitro expansion of GSC/BTIC-like cells. Thus, ROCK pathway inhibition shows promise for future optimization of CSC culture media.
29
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao, Qiulian Wu, Roger E. McLendon et al. · Nature · 2006 · 6.4K citations
Medicine, Cancer Biology, Oncology +16
Identification of a cancer stem cell in human brain tumors.
Sheila K. Singh, Ian D. Clarke, Mizuhiko Terasaki et al. · PubMed · 2003 · 4.9K citations
Medicine, Cell Biology, Oncology +17
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Rossella Galli, Elena Binda, Ugo Orfanelli et al. · Cancer Research · 2004 · 2.6K citations · Full text
Jeongwu Lee, Svetlana Kotliarova, Yuri Kotliarov et al. · Cancer Cell · 2006 · 2.3K citations · Full text
Medicine, Cell Biology, Oncology +16
A ROCK inhibitor permits survival of dissociated human embryonic stem cells
Kiichi Watanabe, Morio Ueno, Daisuke KAMIYA et al. · Nature Biotechnology · 2007 · 2.1K citations